OSS Capital Doubles Stake in Par Pharmaceutical (PRX)
Tweet Send to a Friend
In a 13G filing after the close on Par Pharmaceutical Companies Inc. (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


